Revenue
500 thousand USD
2008-03-31 · USD
Exact inputs and evidence
- Revenue: 500000 USD Source
Fundies. English
Sirtris Pharmaceuticals, Inc.
EDGAR5 filing records in this dataset, filed from 2007-08-13 to 2008-05-14. Explore the available filing history and original sources.
Latest quarter
Operating margin
-2,003.8%
2008-03-31 · %
Operating cash flow
-9.65 million USD
2008-03-31 · USD
Exact inputs and evidence
- Operating Cash Flow: -9647000 USD Source
Free cash flow
-10.2 million USD
2008-03-31 · USD
- Cash and cash equivalents
- 27.7 million USD Source
Exact value
27656000 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- Not available
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2008-05-14.
Financial data available through: 2007-12-31.
Coverage by financial measure
- Revenue: 1 of 11 periods available· newest 2007-12-31
- Operating income: 1 of 11 periods available· newest 2007-12-31
- Net income: 1 of 11 periods available· newest 2007-12-31
- Operating cash flow: 1 of 11 periods available· newest 2007-12-31
- Capital expenditure: 1 of 11 periods available· newest 2007-12-31
- Total assets: 1 of 11 periods available· newest 2007-12-31
- liabilities: No compatible figures in this window
- Current assets: 1 of 11 periods available· newest 2007-12-31
- Current liabilities: 1 of 11 periods available· newest 2007-12-31
- Cash and cash equivalents: 1 of 11 periods available· newest 2007-12-31
- long term debt: No compatible figures in this window
- shares outstanding: No compatible figures in this window
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
No unambiguous prior-year comparison is available for the latest reporting period.
Comparable inputs unavailable for: Revenue, Net income, Operating cash flow, Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2007 2007-01-01 – 2007-12-31
- Revenue USD 68,000 100% of revenue
- Operating costs Derived USD 10.93 million 16,069% of revenue
- Operating income −USD 10.86 million −15,969% of revenue
- Tax, interest and other Derived −USD 1.14 million −1,681% of revenue
- Net income −USD 9.72 million −14,288% of revenue
Cash
- Operating cash flow −USD 9.4 million −13,826% of revenue
- Capital expenditure USD 492,000 724% of revenue
- Free cash flow Derived −USD 9.89 million −14,550% of revenue
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2007 Operating loss: operating costs were 16,069% of revenue.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2007 2007-01-01 – 2007-12-31 | 68000 | 10927000 Derived | -10859000 | -1143000 Derived | -9716000 | -9894000 Derived | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 68K 2007
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2007 | Revenue | 68000 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2007 | Year over year | No prior comparable period |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin -15,969.1% 2007
Net margin -14,288.2% 2007
Free cash flow margin -14,550% 2007
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2007 | Operating margin | -15,969.1% |
|
| 2007 | Net margin | -14,288.2% |
|
| 2007 | Free cash flow margin | -14,550% |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD -9.4M 2007
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2007 | Operating cash flow | -9402000 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
USD -9.9M 2007
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2007 | Free cash flow | -9894000 |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2007-12-31 | Liabilities / assets | Not reported |
|
Current assets to current liabilities
Current assets divided by current liabilities.
14.99× 2007
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2007 | Current assets / current liabilities | 14.99× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2007 2007-01-01 – 2007-12-31 | −USD 9.72 million Exact valueExact value: -9716000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 9.4 million Exact valueExact value: -9402000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 492,000 Exact valueExact value: 492000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 9.89 million Calculation and evidence-9402000 − 492000 USD Exact free cash flow: -9894000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
5 filings · 0 latest values · 0 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001388775, 1388775, edgar:1388775